We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...
Preserving levels of brain glucose metabolism can both slow cognitive decline and reduces the risk of conversion to dementia.
The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...
Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...
Nearly half a million people in England have received a dementia diagnosis in the past year, new NHS figures show.
LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...
Dementia is a syndrome, or a group of associated symptoms, linked to the progressive decline of the brain. Predominantly affecting individuals over 65, dementia can induce memory impairment, ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback